Letter

Postmarketing surveillance of adverse drug reactions.

Br Med J (Clin Res Ed) 1984; 288 doi: https://doi.org/10.1136/bmj.288.6428.1458-b (Published 12 May 1984) Cite this as: Br Med J (Clin Res Ed) 1984;288:1458

This article has a correction. Please see:

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview

Sign in

Log in through your institution

Subscribe